Trials / Conditions / Pharmacokinetics of ASP015K

Pharmacokinetics of ASP015K

13 registered clinical trials studyying Pharmacokinetics of ASP015K.

Status	Trial	Sponsor	Phase
Completed	A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects NCT02141425	Astellas Pharma Global Development, Inc.	Phase 1
Completed	A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects NCT02111317	Astellas Pharma Global Development, Inc.	Phase 1
Completed	Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin NCT01959399	Astellas Pharma Global Development, Inc.	Phase 1
Completed	A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet NCT01929577	Astellas Pharma Global Development, Inc.	Phase 1
Completed	A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate NCT01686217	Astellas Pharma Global Development, Inc.	Phase 1
Completed	A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess i NCT01484964	Astellas Pharma Inc	Phase 1
Completed	A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three NCT01486017	Astellas Pharma Inc	Phase 1
Completed	A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects NCT01406132	Astellas Pharma Inc	Phase 1
Completed	Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers NCT01225224	Astellas Pharma Inc	Phase 1
Completed	Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers NCT01430065	Astellas Pharma Inc	Phase 1
Completed	Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy Voluntee NCT01364987	Astellas Pharma Inc	Phase 1
Completed	A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K NCT01364974	Astellas Pharma Inc	Phase 1
Completed	A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K NCT01387087	Astellas Pharma Inc	Phase 1